trending Market Intelligence /marketintelligence/en/news-insights/trending/vzugkt7ebdghfoway0zmaw2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Bellicum Pharmaceuticals names CFO

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Bellicum Pharmaceuticals names CFO

Bellicum Pharmaceuticals Inc. named Atabak Mokari CFO, effective Dec. 19.

Mokari was CFO and vice president corporate development at IRIDEX Corp., an ophthalmic medical technology company.

Houston-based Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that develops novel, controllable cellular immunotherapies for cancers and orphan inherited blood disorders.